Clinical Trial Update: Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of gemigliptin and acarbose on endothelial function in patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Type 2 Diabetes Mellitus

Drugs mentioned

• Acarbose (acarbose)
• Gemigliptin (gemigliptin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Endothelial Function, Type 2 Diabetes | Phase 4 | Status: UNKNOWN